| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/18/2007 | CN1326859C Thienopyridine derivatives and their preparing process and use |
| 07/18/2007 | CN1326858C Novel tricyclic spiropiperidines or spiropyrrolidines |
| 07/18/2007 | CN1326857C Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
| 07/18/2007 | CN1326855C Ring fused pyrazole derivatives |
| 07/18/2007 | CN1326854C Substituted derivatives of aminofuran-2-Y1-acetic acid and aminothien-2-Y1-acetic acid and use thereof for treating migraines and pain |
| 07/18/2007 | CN1326853C Novel 4-2-furoylaminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 07/18/2007 | CN1326852C Benzofuran derivative |
| 07/18/2007 | CN1326851C Ligustrazine alkyl piperazine derivative, and its preparing method and medicinal composition and use |
| 07/18/2007 | CN1326850C Tricyclic farnesyl protein transferase inhibitors |
| 07/18/2007 | CN1326848C Aminopyrazole derivatives |
| 07/18/2007 | CN1326847C Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 07/18/2007 | CN1326845C Process for preparing bis-phenyl fluorozine |
| 07/18/2007 | CN1326841C Arylalkane-sulfonamides having endothelin-antagonist activity |
| 07/18/2007 | CN1326839C 2-substituted-4,4,5,5-tetramethyl-1-hydroxyimidazoline, and its synthesis and use |
| 07/18/2007 | CN1326838C Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 07/18/2007 | CN1326837C Process for preparing leukotrienes antagonist |
| 07/18/2007 | CN1326832C Double salts of fumaric acid with carnitine and amino acid and food supplements, dietary supplements and drugs contg. same |
| 07/18/2007 | CN1326830C Process for preparing nitrooxyderivatives of naproxen |
| 07/18/2007 | CN1326823C Cyclic alcohol derivative keratinous sponge alcohol, and its preparing method and use |
| 07/18/2007 | CN1326814C Process for preparing Erigeron breviscapus active component |
| 07/18/2007 | CN1326577C N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 07/18/2007 | CN1326569C Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative |
| 07/18/2007 | CN1326556C Chinese medicinal formulation for activating blood circulation, stopping pain and adjusting chemical balance |
| 07/18/2007 | CN1326527C Dispersible tablet of puerarin and its preparation process |
| 07/18/2007 | CN1326526C Prolonged release pharmaceutical composition |
| 07/18/2007 | CN1326525C 10-hydroxy camptothecin long cyclic liposome and its freeze aried preparation |
| 07/18/2007 | CN1326524C Stable liquid preparation |
| 07/18/2007 | CN1326523C Atineoplastic combinations |
| 07/18/2007 | CN1326522C Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain |
| 07/18/2007 | CN1326521C Use for 3-indole aldehydes and its derivatives in preparation of anti-tumour medication |
| 07/18/2007 | CN1326520C A pharmaceutical composition and application thereof in preparation of medicine for preventing or treating cerebrovascular and cardiovascular disease |
| 07/18/2007 | CN1326467C Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes |
| 07/18/2007 | CN101001865A Purine nucleotide derivatives |
| 07/18/2007 | CN101001863A Tanaproget derivatives, metabolites, and uses thereof |
| 07/18/2007 | CN101001862A Tricyclic compounds and their use as MGLUR1 antagonists |
| 07/18/2007 | CN101001861A Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon |
| 07/18/2007 | CN101001860A Heterocyclic antiviral compounds |
| 07/18/2007 | CN101001859A Pyrrolopyridine derivatives |
| 07/18/2007 | CN101001858A S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor |
| 07/18/2007 | CN101001857A 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 07/18/2007 | CN101001856A Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
| 07/18/2007 | CN101001854A Highly selective novel amidation method |
| 07/18/2007 | CN101001853A Oxindole oxazolidinones as antibacterial agents |
| 07/18/2007 | CN101001852A Pyrazole derivative |
| 07/18/2007 | CN101001851A Hydroxyamide compounds having activity as inhibitors of histone deacetylase (HDAC) |
| 07/18/2007 | CN101001850A Amido compounds and their use as pharmaceuticals |
| 07/18/2007 | CN101001849A Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders |
| 07/18/2007 | CN101001847A 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 07/18/2007 | CN101001846A Novel alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 07/18/2007 | CN101001845A Substituted quinazolones as anti-cancer agents. |
| 07/18/2007 | CN101001844A Mercaptoimidazoles as CCR2 receptor antagonists |
| 07/18/2007 | CN101001843A Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 07/18/2007 | CN101001841A Tetrahydroquinolones and aza-analogues thereof for use as DPP-IV inhibitors in the treatement of diabetes |
| 07/18/2007 | CN101001840A Therapeutic compounds: pyridine as scaffold |
| 07/18/2007 | CN101001838A DPP-IV inhibitors |
| 07/18/2007 | CN101001837A Indole derivatives comprising an acetylene group as PPAR activators |
| 07/18/2007 | CN101001836A Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/18/2007 | CN101001834A Nonpeptide inhibitors of matrix metalloproteinases |
| 07/18/2007 | CN101001833A Organic compounds |
| 07/18/2007 | CN101001670A Compositions for sleeping disorders |
| 07/18/2007 | CN101001633A Treatment of lung diseases and pre-lung disease conditions |
| 07/18/2007 | CN101001632A Compositions and methods of use of dimer digallates |
| 07/18/2007 | CN101001631A Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 07/18/2007 | CN101001630A Combination of selective noradrenalin reabsorption inhibitor and PDEV inhibitor |
| 07/18/2007 | CN101001629A Medicinal composition |
| 07/18/2007 | CN101001628A Anti-HIV quinuclidine compounds |
| 07/18/2007 | CN101001627A Pyrazolone compounds useful for treatment of cerebrovascular disorders associated with ischemic stroke |
| 07/18/2007 | CN101001626A Pyrazole derivatives for treating conditions mediated by activation of the adenosine A2b or A3 receptor |
| 07/18/2007 | CN101001625A Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof |
| 07/18/2007 | CN101001624A Compositions comprising flavonoids and tocotrienols and methods thereof |
| 07/18/2007 | CN101001623A Anticancer effect enhancer |
| 07/18/2007 | CN101001622A Capsule stable against mastication |
| 07/18/2007 | CN101001621A A pharmaceutical composition comprising gabapentin |
| 07/18/2007 | CN101001620A Use of alpha-ketoglutarate and related compounds for lowering plasma lipids |
| 07/18/2007 | CN101001619A Combination of bupropion and a second compound for affectingweight loss |
| 07/18/2007 | CN101001618A Hydroalcoholic depigmentation gel comprising mequinol and adapalene |
| 07/18/2007 | CN101001617A Antitumor agent |
| 07/18/2007 | CN101001616A Polymeric adhesive matrix with salified carboxylic groups for transdermal use |
| 07/18/2007 | CN101001608A Galenic applications of self-emulsifying mixtures of lipidic excipients |
| 07/18/2007 | CN101001606A Preventing skin damage |
| 07/18/2007 | CN101001543A Lipoic acid concentrate |
| 07/18/2007 | CN101001530A Methods of administering water-soluble prodrugs of propofol for extended sedation |
| 07/18/2007 | CN100999737A Trichina paramyosin gene and application thereof |
| 07/18/2007 | CN100999555A Process for sulphofication of mucopolysaccharide with galactosamine hexose aldehydic acid disaccharide based structure |
| 07/18/2007 | CN100999539A Erythromycin A-9 oxime derivate |
| 07/18/2007 | CN100999535A 15-(14-deoxy 11,12 dehydro) andrographolide carbonic side derivate and preparation process thereof |
| 07/18/2007 | CN100999527A Selenaza aromatic heterocyclic compound with anti-tumor activty and its preparation process and application |
| 07/18/2007 | CN100999524A Taxad phenol derivate with anti-tumor activity |
| 07/18/2007 | CN100999521A Crystal anti-choline medicine thiatropic bromoammonium |
| 07/18/2007 | CN100999520A Isoandrographolide analogue and its preparation process |
| 07/18/2007 | CN100999519A (-) poly thaazoleazine methylsulfonate, its preparation process and use |
| 07/18/2007 | CN100999518A Voriconazole derivate and preparation process thereof |
| 07/18/2007 | CN100999517A Pyrazole formylamine derivate, its pharmaceutical composition and preparation process |
| 07/18/2007 | CN100999513A Production of delta 9 tetrahydrocannabinol |
| 07/18/2007 | CN100999512A Isochromanone 4 derivate, its preparation process and therapeutic use |
| 07/18/2007 | CN100999510A Preparation of noncrystal form ede plene oxalate and its coprecipitate |
| 07/18/2007 | CN100999503A Hexanary carbocycle azole like nucleoside analogue, its synthesizing process and use in anti virus and tumor thereof |
| 07/18/2007 | CN100999501A Process for the preparation of 2-methyl piperazine derivatives |
| 07/18/2007 | CN100999500A Onitrodazole precursor drug and its preparation process and use |
| 07/18/2007 | CN100999496A Compound of polyphenols with aza-containing heterocyclic modified and use thereof |